PERITONEAL MESOTHELIOMA
Clinical trials for PERITONEAL MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new PERITONEAL MESOTHELIOMA trials appear
Sign up with your email to follow new studies for PERITONEAL MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New chemo combo aims to extend life in rare abdominal cancer
Disease control TerminatedThis study tests whether adding a special chemotherapy spray (PIPAC) directly into the abdomen to standard IV chemo can help people with peritoneal mesothelioma live longer. About 66 adults who have not had prior treatment will be randomly assigned to get either standard chemo al…
Matched conditions: PERITONEAL MESOTHELIOMA
Phase: PHASE2 • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New hope for rare cancers: drug trial targets tough tumors
Disease control TerminatedThis study tests a drug called XmAb20717 in 140 adults with advanced rare cancers, such as mesothelioma and Hodgkin's lymphoma. The goal is to see if the drug can shrink tumors and how safe it is. The trial is currently on hold.
Matched conditions: PERITONEAL MESOTHELIOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:40 UTC